Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Turkish Stocks Fall 6%, Triggering Market-wide Circuit Breaker - Bloomberg
Twist Bioscience Corporation (TWST) Misses Q4 EPS by 5c
November 22, 2021 7:34 AM ESTTwist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.84), $0.05 worse than the analyst estimate of ($0.79). Revenue for the quarter came in at $38 million versus the consensus estimate of $37.02 million.
GUIDANCE:
Twist Bioscience Corporation sees FY2022 revenue of $183-193 million, versus the... More
